Trial Profile
Phase II study of everolimus (E) in refractory germ cell tumors (GCTs).
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2012
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Germ cell and embryonal neoplasms; Germ cell cancer
- Focus Therapeutic Use
- 03 Jul 2012 New trial record